임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
36건 표시
- 1/2상모집 중· Metastatic Prostate CancerPhase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Metastatic Prostate CancerFirst-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Advanced or Metastatic Non-small Cell Lung CancerA Platform Study in Non-Small Cell Lung Cancer (NSCLC)
리드: 아스트라제네카
- 1/2상모집 중· B-cell Acute Lymphoblastic Leukemia (B-ALL)Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
리드: 아스트라제네카
- 1/2상모집 중· Metastatic Prostate CancerStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· B-cell Non-Hodgkin LymphomaA Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
리드: 아스트라제네카
- 1/2상모집 중· Lupus Erythematosus, SystemicA Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
리드: 아스트라제네카
- 1/2상모집 중· Hepatocellular Carcinoma (HCC)Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
협력: 아스트라제네카
- 1/2상모집 중· Hepatocellular CarcinomaFirst in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
리드: 아스트라제네카
- 1/2상모집 중· Chronic Lymphocytic LeukaemiaA Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
리드: 아스트라제네카
- 1/2상모집 중· B-cell MalignanciesA Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
리드: 아스트라제네카
- 1/2상모집 중· Metastatic Prostate CancerStudy of AZD0754 in Participants With Metastatic Prostate Cancer
리드: 아스트라제네카
- 1/2상모집 중· Advanced Solid Tumors That Are MTAP DeficientA Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
리드: 아스트라제네카
- 1/2상모집 중· Metastatic Pancreatic CancerCombining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy
협력: 아스트라제네카
- 1/2상모집 중· B-cell Acute Lymphoblastic Leukemia (B-ALL)AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
리드: 아스트라제네카
- 1/2상모집 중· ER+ HER2- Advanced Breast CancerA First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
리드: 아스트라제네카
- 1/2상모집 중· Multiple MyelomaAZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
리드: 아스트라제네카
- 1/2상모집 중· Relapsed/Refractory Multiple MyelomaAZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
리드: 아스트라제네카
- 1/2상모집 중· Gastric CancerStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
리드: 아스트라제네카
- 1/2상모집 중· Ovarian CancerPhase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
리드: 아스트라제네카
- 1/2상모집 중· Diffuse Large B-Cell LymphomaAcalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
협력: 아스트라제네카
- 1/2상모집 중· Advanced Solid MalignanciesStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
리드: 아스트라제네카
- 1/2상모집 중· Bladder CancerDURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr
협력: 아스트라제네카
- 1/2상모집 중· Breast CancerA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
리드: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.